It is commonly accepted that hyperinsulinemia is consequent to resistance to insulin action in glucose metabolism, leading to increased glycaemia, which in turn stimulates the pancreatic β-cell to release insulin to avoid a more severe hyperglycemia [2,3]. The gene discussed is INS; the disease is Hyperinsulinemia.